Slowly evolving immune-mediated diabetes, or<unk>  <unk> , is a form of diabetes that exhibits clinical features similar to both type 1 diabetes (T1D) and type 2 diabetes (T2D). It is an<unk>  form of diabetes, similar to T1D, but patients with<unk>  often show insulin resistance, similar to T2D, and share some risk factors for the disease with T2D. Studies have shown that<unk>  patients have certain types of antibodies against the insulin-producing cells, and that these cells stop producing insulin more slowly than in T1D patients.<unk>  appears to share genetic risk factors with both T1D and T2D but is genetically distinct from both. Within the<unk>  patient group, a genetic and phenotypic heterogeneity has been observed with varying degrees of insulin resistance and<unk> ty. With the knowledge we have today,<unk>  can thus be described as a hybrid form of T1D and T2D, showing phenotypic and genotypic similarities with both, as well as variation within<unk>  regarding the degree of<unk> ty and insulin resistance. The concept of<unk>  was first introduced in 1993, though The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus does not recognize the term, instead including it under the standard definition of diabetes mellitus type 1.
Latent autoimmune diabetes in adults
Hepatitis C and HIV coinfection
Lifestyle causes of type 2 diabetes
Smoking in South Korea
Type 3c diabetes
Steroid use in Bollywood
Tuberculosis in relation to HIV
Genetic causes of type 2 diabetes